Last reviewed · How we verify
NCT03853824: ASOS-2
African Surgical OutcomeS-2 (ASOS-2) Trial
NA trial testing Increased postoperative surveillance in Surgery in 27,507 participants. Completed in 31 August 2020.
31 August 2020
Quick facts
| Lead sponsor | University of Cape Town |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 27,507 |
| Start date | 6 May 2019 |
| Primary completion | 31 August 2020 |
| Estimated completion | 31 August 2020 |
| Sites | 1 location across South Africa |
Drugs / interventions tested
- Increased postoperative surveillance
- Usual postoperative care
Conditions studied
Sponsor
University of Cape Town
Who can join
18 and older, any sex, with Surgery or Morality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An international, multicentre, African cluster randomised trial. Primary objective : To determine whether increased postoperative surveillance in high-risk adult surgical patients reduces overall in-hospital mortality in surgical patients aged 18 years and over in Africa. Primary outcome measure: In-hospital mortality, censored at 30 days if the patient is still alive and in-hospital. Secondary objective: To determine whether increased postoperative surveillance in high-risk adult surgical patients reduces the overall incidence of the composite of severe in-hospital complications and mortality in adult surgical patients aged 18 years and over in Africa. Secondary outcome measure: Composite of severe in-hospital complications and mortality, censored at 30 days if the patient is still alive and in-hospital.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Enhanced postoperative surveillance versus standard of care to reduce mortality among adult surgical patients in Africa (ASOS-2): a cluster-randomised controlled trial.
ASOS-2 Investigators. · · 2021 · cited 43× · PMID 34418380 · DOI 10.1016/s2214-109x(21)00291-6 -
Understanding the performance of a pan-African intervention to reduce postoperative mortality: a mixed-methods process evaluation of the ASOS-2 trial.
Vickery N, Stephens T, du Toit L, van Straaten D, et al · · 2021 · cited 7× · PMID 34446223 · DOI 10.1016/j.bja.2021.07.001
Verify or expand the search:
- PubMed search for NCT03853824
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Surgery
Currently open trials in the same condition.
- NCT07369921 — Pediatric Pilonidal Sinus Surgical Treatment · NA · recruiting
- NCT07362303 — Neuralert Stroke Monitor Trial · NA · recruiting
- NCT07404163 — Walkway Used in Postoperative Mobilization · NA · active not recruiting
- NCT07218289 — Green Light for Post-Operative Wellness · NA · recruiting
- NCT07342751 — The Effect of Listening to Music During Mobilization on Pain and Fear in Children Undergoing Abdominal Surgery · NA · active not recruiting
Other University of Cape Town trials
Trials by the same sponsor.
- NCT06997328 — '5 Rs to Rescue' A Cluster Trial With an Embedded Process Evaluation · recruiting
- NCT06431321 — Evaluation of a 2-session Parent Training Programme for Caregivers of Younger Children in Zimbabwe · NA · not yet recruiting
- NCT06051526 — The African Critical Illness Outcomes Study · completed
- NCT05723484 — Comparing a Novel Point-of-care Cytokine Biomarker Lateral Flow Test With Nucleic Acid Amplification Tests for Detection · completed
- NCT05681871 — South African Paediatric Surgical Outcomes Study 2 · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03853824 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cape Town
- Last refreshed: 10 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03853824.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing